Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson save search
Contineum Therapeutics Announces Pricing of Initial Public Offering - April 05, 2024
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Contineum Therapeutics Announces Pricing of Initial Public Offering
Published: 2024-04-05 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight
Published: 2024-04-04 (Crawled : 22:00) - prnewswire.com
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: -0.52%
H: 0.71%
C: 0.71%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
SLDB | $9.26 -7.31% -8.12% 140K
|
Health Technology
|
| O: -0.73%
H: 1.3%
C: -1.06%
growth market
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
drug collaboration therapeutics
Biopharma Layoff Tracker 2024: Carisma, Omega, Xilio and More Cut Staff
Published: 2024-04-04 (Crawled : 17:00) - biospace.com/
RLYB | $1.67 -5.11% -4.76% 270K
|
|
| O: 1.2%
H: 0.0%
C: -6.51%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
VXRT | $0.8423 -2.75% -3.6% 880K
|
Health Technology
|
| O: -0.81%
H: 6.56%
C: -7.38%
TXMD | $1.89 4.55% 5.7K
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -0.44%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
PTCT | $24.69 -1.87% -1.82% 820K
|
Health Technology
|
| O: 0.45%
H: 1.0%
C: -4.5%
NKTR | $1.32 -2.22% -3.85% 2.4M
|
Health Technology
|
| O: 3.85%
H: 28.7%
C: 22.22%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: -0.66%
GLPG | $28.91 -1.06% -1.11% 130K
|
Health Technology
|
| O: 0.44%
H: 0.69%
C: -0.38%
AMRN | $0.8718 -4.94% -4.23% 1M
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: -0.93%
GOOGL | News S | $156.01 0.35% 0.32% 16M
|
Technology Services
|
| O: -0.76%
H: 0.0%
C: 0.0%
GOOG | News S | $157.46 0.37% 0.39% 12M
|
Technology Services
|
| O: -0.84%
H: 0.0%
C: 0.0%
OCX J | $2.56 -1.16% -2.78% 36K
|
Health Technology
|
| O: -3.4%
H: 3.52%
C: 3.52%
biopharma
Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest
Published: 2024-04-04 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
fda approval
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
TRIB | $1.88 2.17% -0.55% 23K
|
Health Technology
|
| O: -0.99%
H: 2.0%
C: 2.0%
biotech business year financial results
HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication
Published: 2024-04-04 (Crawled : 11:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
publication care
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
Published: 2024-04-04 (Crawled : 11:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
NXTC | $1.57 3.97% 3.82% 39K
|
Health Technology
|
| O: -4.17%
H: 8.26%
C: -6.09%
Biden, Sanders Target Drug Prices at White House Event
Published: 2024-04-03 (Crawled : 22:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
drug house
Genmab, Kintara, Ginkgo and More Continue 2024 M&A Upswing
Published: 2024-04-03 (Crawled : 14:30) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
Major shareholder announcement – Swedbank Robur Fonder AB
Published: 2024-04-03 (Crawled : 14:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
announcement
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $29.94 -0.33% -0.6% 970K
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
Retinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsight
Published: 2024-04-02 (Crawled : 22:00) - prnewswire.com
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: -0.65%
H: 2.43%
C: -0.28%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
market
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
NBTX | $5.5 2.23% -0.75% 28K
|
Manufacturing
|
| O: 3.11%
H: 1.19%
C: -2.54%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
lung cancer treatment
Biopharma Layoff Tracker 2024: Carisma, Omega, Xilio and More Cut Staff
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
RLYB | $1.67 -5.11% -4.76% 270K
|
|
| O: -1.14%
H: 0.0%
C: -1.72%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
TXMD | $1.89 4.55% 5.7K
|
Health Technology
|
| O: -0.43%
H: 2.6%
C: -2.81%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
NKTR | $1.32 -2.22% -3.85% 2.4M
|
Health Technology
|
| O: -0.12%
H: 12.96%
C: 5.2%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.22%
GLPG | $28.91 -1.06% -1.11% 130K
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: -1.09%
AMRN | $0.8718 -4.94% -4.23% 1M
|
Health Technology
|
| O: -0.86%
H: 15.51%
C: 13.22%
GOOGL | News S | $156.01 0.35% 0.32% 16M
|
Technology Services
|
| O: -1.28%
H: 0.78%
C: 0.69%
GOOG | News S | $157.46 0.37% 0.39% 12M
|
Technology Services
|
| O: -1.12%
H: 0.8%
C: 0.72%
OCX J | $2.56 -1.16% -2.78% 36K
|
Health Technology
|
| O: -4.36%
H: 2.81%
C: 2.81%
biopharma
Infinant Health Announces Submission of Orphan Drug Designation Application
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug health designation application submission
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $29.94 -0.33% -0.6% 970K
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals ...
Published: 2024-04-02 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug patent schizophrenia
Teva, Viatris Again Challenge J&J Patent for Schizophrenia Drug with Appeals Court Win
Published: 2024-04-02 (Crawled : 12:30) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug patent schizophrenia
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.